Partial restoration of immune response in Hepatitis C patients after viral clearance by direct-acting antiviral therapy.

Partial restoration of immune response in Hepatitis C patients after viral clearance by direct-acting antiviral therapy.

<h4>Background & aims</h4>HCV CD4+ and CD8+ specific T cells responses are functionally impaired during chronic hepatitis C infection. DAAs therapies eradicate HCV infection in more than 95% of treated patients. However, the impact of HCV elimination on immune responses remain contro...

Full description

Bibliographic Details
Main Authors:	Meritxell Llorens-Revull, Maria Isabel Costafreda, Angie Rico, Mercedes Guerrero-Murillo, Maria Eugenia Soria, Sofía Píriz-Ruzo, Elena Vargas-Accarino, Pablo Gabriel-Medina, Francisco Rodríguez-Frías, Mar Riveiro-Barciela, Celia Perales, Josep Quer, Silvia Sauleda, Juan Ignacio Esteban, Marta Bes
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2021-01-01
Series:	PLoS ONE
Online Access:	https://doi.org/10.1371/journal.pone.0254243

Similar Items

Effect of Hepatitis E Virus RNA Universal Blood Donor Screening, Catalonia, Spain, 2017‒2020
by: Marta Bes, et al.
Published: (2022-01-01)

Specific Plasma MicroRNA Signatures Underlying the Clinical Outcomes of Hepatitis E Virus Infection
by: Maria I. Costafreda, et al.
Published: (2023-02-01)

Comparison of Extracellular Vesicle Isolation Methods for miRNA Sequencing
by: Meritxell Llorens-Revull, et al.
Published: (2023-07-01)

Study of Quasispecies Complexity and Liver Damage Progression after Liver Transplantation in Hepatitis C Virus Infected Patients
by: Meritxell Llorens-Revull, et al.
Published: (2021-10-01)

Editorial: Multidisciplinary management of cancer patients with immune-related adverse events from checkpoint inhibitors
by: Mar Riveiro-Barciela, et al.
Published: (2023-01-01)

In-Host HEV Quasispecies Evolution Shows the Limits of Mutagenic Antiviral Treatments
by: Sergi Colomer-Castell, et al.
Published: (2023-12-01)

Hepatitis E virus: new faces of an old infection
by: Mar Riveiro-Barciela, et al.
Published: (2013-11-01)

Immunotherapy and the Spectrum of Kidney Disease: Should We Individualize the Treatment?
by: Sheila Bermejo, et al.
Published: (2022-06-01)

Cirrhosis, liver transplantation and HIV infection are risk factors associated with hepatitis E virus infection.
by: Mar Riveiro-Barciela, et al.
Published: (2014-01-01)

Complex Genotype Mixtures Analyzed by Deep Sequencing in Two Different Regions of Hepatitis B Virus.
by: Andrea Caballero, et al.
Published: (2015-01-01)

New strategies for the treatment of hepatitis C virus infection and implications of resistance to new direct-acting antiviral agents
by: Josep Quer, et al.
Published: (2010-11-01)

Solved the enigma of pediatric severe acute hepatitis of unknown origin?
by: Francisco Rodriguez-Frias, et al.
Published: (2023-09-01)

Rare haplotype load as marker for lethal mutagenesis.
by: Josep Gregori, et al.
Published: (2018-01-01)

Complete clearance of cutaneous warts with hydroxychloroquine: Antiviral action?
by: Premanshu Bhushan, et al.
Published: (2014-01-01)

LINK-B: study protocol of a retrospective and prospective project for identification and linkage to care of people living with hepatitis B in a large health area of Barcelona
by: Ariadna Rando, et al.
Published: (2022-12-01)

Hepatitis B Virus Variants with Multiple Insertions and/or Deletions in the X Open Reading Frame 3′ End: Common Members of Viral Quasispecies in Chronic Hepatitis B Patients
by: Selene García-García, et al.
Published: (2022-05-01)

Quasispecies Fitness Partition to Characterize the Molecular Status of a Viral Population. Negative Effect of Early Ribavirin Discontinuation in a Chronically Infected HEV Patient
by: Josep Gregori, et al.
Published: (2022-11-01)

Sophisticated viral quasispecies with a genotype-related pattern of mutations in the hepatitis B X gene of HBeAg-ve chronically infected patients
by: Maria Francesca Cortese, et al.
Published: (2021-02-01)

Hepatitis C Clearance by Direct-Acting Antivirals Impacts Glucose and Lipid Homeostasis
by: Christiana Graf, et al.
Published: (2020-08-01)

TNFα Impairs Rhabdoviral Clearance by Inhibiting the Host Autophagic Antiviral Response.
by: Raquel Espín-Palazón, et al.
Published: (2016-06-01)

HBsAg protein composition and clinical outcomes in chronic hepatitis D and variations across HBeAg-negative chronic HBsAg carriers
by: Luisa Roade, et al.
Published: (2023-10-01)

Efficacy decrease of antiviral agents when administered to ongoing hepatitis C virus infections in cell culture
by: Carlos García-Crespo, et al.
Published: (2022-08-01)

Inspecting the Ribozyme Region of Hepatitis Delta Virus Genotype 1: Conservation and Variability
by: Beatriz Pacin-Ruiz, et al.
Published: (2022-01-01)

Aggressive recurrence of Non-Hodgkin's Lymphoma after successful clearance of hepatitis C virus with direct acting antivirals
by: Dimitrios N. Samonakis, et al.
Published: (2021-03-01)

Ultra Deep Sequencing of Circulating Cell-Free DNA as a Potential Tool for Hepatocellular Carcinoma Management
by: Mónica Higuera, et al.
Published: (2022-08-01)

The combined regimens of antiviral therapy might not be useful for the viral clearance of severe COVID-19 cases
by: Xuan Li, et al.
Published: (2021-11-01)

Editorial: Virology today in Spain. Selected topics from Spanish virology
by: Covadonga Alonso, et al.
Published: (2024-01-01)

Nontypeable Haemophilus influenzae clearance by alveolar macrophages is impaired by exposure to cigarette smoke.
by: Martí-Lliteras, P, et al.
Published: (2009)

Risk of Hepatocellular Carcinoma after HCV Clearance by Direct-Acting Antivirals Treatment Predictive Factors and Role of Epigenetics
by: Luca Rinaldi, et al.
Published: (2020-05-01)

Lethal Mutagenesis of Hepatitis C Virus Induced by Favipiravir.
by: Ana I de Ávila, et al.
Published: (2016-01-01)

Expert Clinical Management of Severe Immune-Related Adverse Events: Results from a Multicenter Survey on Hot Topics for Management
by: Mar Riveiro-Barciela, et al.
Published: (2022-10-01)

Corrigendum to ‘Chronic hepatitis D associated with worse patient-reported outcomes than chronic hepatitis B’ [JHEP Reports 3 (2021)]
by: Maria Buti, et al.
Published: (2022-09-01)

Chronic hepatitis D associated with worse patient-reported outcomes than chronic hepatitis B
by: Maria Buti, et al.
Published: (2021-06-01)

Ultrasensitive HCV RNA Quantification in Antiviral Triple Therapy: New Insight on Viral Clearance Dynamics and Treatment Outcome Predictors.
by: Anna Rosa Garbuglia, et al.
Published: (2016-01-01)

Characterizing SARS-CoV-2 viral clearance kinetics to improve the design of antiviral pharmacometric studies
by: Watson, JA, et al.
Published: (2022)

Enterovirus 71 Antagonizes Antiviral Effects of Type III Interferon and Evades the Clearance of Intestinal Intraepithelial Lymphocytes
by: Yuanmin Dong, et al.
Published: (2022-02-01)

The Low Incidence of Viral Hepatitis Reactivation Among Subjects on Immunotherapy Reduces the Impact of Suboptimal Screening Rate
by: Laia Aceituno, et al.
Published: (2022-07-01)

Impact of the COVID-19 pandemic on hepatitis B and C elimination: An EASL survey
by: Loreta A. Kondili, et al.
Published: (2022-09-01)

Implementation of anti-HDV reflex testing among HBsAg-positive individuals increases testing for hepatitis D
by: Adriana Palom, et al.
Published: (2022-10-01)

Standardized Hepatitis B Virus RNA Quantification in Untreated and Treated Chronic Patients: a Promising Marker of Infection Follow-Up
by: Maria Francesca Cortese, et al.
Published: (2022-04-01)